Sophie Liu, Ph.D.
About Sophie Liu, Ph.D.
Sophie Liu, Ph.D., is the Director of the R&D Head Office at BeiGene in Shanghai, China, with a background in biomedical sciences and extensive experience in oncology drug development.
Title
Sophie Liu, Ph.D., is the Director, R&D Head Office at BeiGene in Shanghai, China. She has held this position since joining BeiGene.
Company
Sophie Liu currently works at BeiGene, a biotechnology company focused on developing innovative cancer treatments. The company is based in Shanghai, China, where she leads the R&D Head Office.
Previous Roles
Before joining BeiGene, Sophie Liu held several notable positions. She was Associate Director - Strategy & Business Consulting at Bayer from 2018 to 2021. Prior to that, she was a Senior Consultant at Oliver Wyman from 2016 to 2018. Her early career includes a role as a Predoctoral Fellow at the National Institutes of Health from 2011 to 2015.
Education and Expertise
Sophie Liu studied Biomedical Sciences at the National Institutes of Health, USA, earning her Doctor of Philosophy (PhD) between 2011 and 2015. She also holds a BSc in Biochemistry from The Chinese University of Hong Kong, which she completed from 2007 to 2011. Her extensive background in biomedical sciences and biochemistry establishes her expertise in cancer research and immunotherapy.
Achievements
Sophie Liu has published several peer-reviewed articles on cancer immunotherapy. She received the 'Young Investigator Award' at the International Conference on Cancer Research in 2019. She also delivered a keynote speech on 'Innovations in Cancer Treatment' at the 2022 Global Biotech Summit.